China Pharma Holdings (CPHI) Buildings (2011 - 2023)

China Pharma Holdings has reported Buildings for 13 years, with the latest figure at $9.1 million in Q2 2023.

• For the quarter ending Q2 2023, Buildings fell 7.12% year-over-year to $9.1 million; the trailing twelve-month figure through Jun 2023 stood at $9.1 million (down 7.12% YoY), and the FY2022 full-year result was $9.4 million, down 8.46% from the prior year.
• Buildings for Q2 2023 stood at $9.1 million, down from $9.5 million in the prior quarter.
• The five-year high for Buildings was $10.3 million in Q1 2022, with the low at $9.1 million in Q2 2023.
• Historically, Buildings has averaged $9.7 million across 5 years, with a median of $9.6 million in 2020.
• Annual changes were most pronounced in 2021 — Buildings gained 9.59% — and 2022, when it slipped 8.65%.
• China Pharma Holdings' Buildings stood at $9.4 million in 2019, then climbed by 6.92% to $10.0 million in 2020, then gained by 2.34% to $10.3 million in 2021, then retreated by 8.46% to $9.4 million in 2022, then fell by 3.61% to $9.1 million in 2023.
• The last three Buildings figures came in at $9.1 million (Q2 2023), $9.5 million (Q1 2023), and $9.4 million (Q4 2022), per Business Quant data.